Cell proliferation and hepatocarcinogenesis in rat initiated by diethylnitrosamine and promoted by phenobarbital: Potential roles of early DNA damage and liver metallothionein expression

Life Sciences

Volumn 81, Issue 6, 2007, Pages 489-499

  Chakraborty, Tridib ^a   Chatterjee, Amrita ^a   Rana, Ajay ^b   Srivastawa, Sunil ^a   Damodaran, Suresh ^a   Chatterjee, Malay ^a  

^a JADAVPUR UNIVERSITY   (India)

^b Texas A and M University   (United States)

Author keywords

Cell proliferation; Diethylnitrosamine; DNA strand breaks; Hepatocarcinogenesis; Ki 67; Metallothionein

Indexed keywords

BROXURIDINE; CELL DNA; COPPER; DEOXYURIDINE; DIETHYLNITROSAMINE; DNA; KI 67 ANTIGEN; METALLOTHIONEIN; PHENOBARBITAL; SINGLE STRANDED DNA; ZINC;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL LABELING; CELL LEVEL; CELL PROLIFERATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA DAMAGE; DNA STRAND BREAKAGE; IMMUNOREACTIVITY; LIVER CARCINOGENESIS; LIVER CELL; LIVER METABOLISM; MALE; NONHUMAN; PROTEIN EXPRESSION; RAT; SPRAGUE DAWLEY RAT;

ANIMALS; ANTIMETABOLITES; BROMODEOXYURIDINE; CARCINOGENS; CELL PROLIFERATION; COPPER; DIETHYLNITROSAMINE; DNA DAMAGE; DNA HELICASES; KI-67 ANTIGEN; LIVER; LIVER NEOPLASMS; MALE; METALLOTHIONEIN; PHENOBARBITAL; RATS; RATS, SPRAGUE-DAWLEY; SPECTROPHOTOMETRY, ATOMIC; ZINC;

RATTUS;

EID: 34547407886     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2007.06.023     Document Type: Article

References (65)

1. Abonobi S., Lombardi B., and Shinozuka H. Stimulation of DNA synthesis and cell proliferation in the liver of rats fed a choline-devoid diet and their suppression by phenobarbital. Cancer Research 42 2 (1982) 412-415
2. Basak J. Estimation of single-strand breaks induced in the dried film of DNA by high energy alpha particle from a cyclotron. Indian Journal of Biochemistry and Biophysics 33 1 (1996) 35-38
3. Bishayee A., and Chatterjee M. Inhibitory effect of vanadium on rat liver carcinogenesis initiated with diethylnitrosamine and promoted by phenobarbital. British Journal of Cancer 71 7 (1995) 1214-1220
4. Cai L., Wang G.J., Xu Z.L., Deng D.X., Chakrabarti S., and Cherian M.G. Metallothionein and apoptosis in primary human hepatocellular carcinoma (HCC) from northern China. Anticancer Research 18 6B (1998) 4667-4672
5. Deng D.X., Chakrabarti S., Waalkes M.P., and Cherian M.G. Metallothionein and apoptosis in primary human hepatocellular carcinoma and metastatic adenocarcinoma. Histopathology 32 4 (1998) 340-347
6. Dragon Y.P., Hully J., Crow R., Mass M., and Pitot H.C. Incorporation of bromodeoxyuridine in glutathione S-transferase-positive hepatocytes during rat multistage hepatocarcinogenesis. Carcinogenesis 15 9 (1994) 1939-1947
7. Eagon P.K., Teepe A.G., Elm M.S., Tadic S.D., Epley M.J., Beiler B.E., Shinozuka H., and Rao K.N. Hepatic hyperplasia and cancer in rats: alterations in copper metabolism. Carcinogenesis 20 6 (1999) 1091-1096
8. Ebara M., Fukuda H., Hatano R., Saisho H., Nagato Y., Suzuki K., Nakajima K., Yukawa M., Kondo F., Nakayama A., and Sakurai H. Relationship between copper, zinc and metallothionein in hepatocellular carcinoma and its surrounding liver parenchyma. Journal of Hepatology 33 3 (2000) 415-422
9. Ebara M., Fukuda H., Kojima Y., Morimoto N., Yoshikawa M., Sugiura N., Satoh T., Kondo F., Yukawa M., Matsumoto T., and Saisho H. Small hepatocellular carcinoma: relationship of signal intensity to histopathologic findings and metal content of the tumor and surrounding hepatic parenchyma. Radiology 210 1 (1999) 81-88
10. Endo T., Yoshikawa M., Ebara M., Kato K., Sunaga M., Fukuda H., Hayasaka A., Kondo F., Sugiura N., and Saisho H. Immunohistochemical metallothionein expression in hepatocellular carcinoma: relation to tumor progression and chemoresistance to platinum agents. Journal of Gastroenterology 39 12 (2004) 1196-1201
11. Fabisiak J.P., Pearce L.L., Borisenko G.G., Tyurina Y.Y., Tyurin V.A., and Razzack J. Bifunctional anti/prooxidant potential of metallothionein: redox signaling of copper binding and release. Antioxidants and Redox Signaling 1 3 (1999) 349-364
12. Farber E. The multistep nature of cancer development. Cancer Research 44 12 Pt 1 (1984) 4217-4223
13. Farber E. Cellular biochemistry of the stepwise development of cancer with chemicals. Cancer Research 44 12 Pt 1 (1984) 5463-5474
14. Farber E. Hepatocye proliferation in stepwise development of experimental liver cell cancer. Digestive Diseases and Sciences 36 7 (1991) 973-978
15. Gupta R.C. Nonrandom binding of the carcinogen N-hydroxy-2-acetylaminofluorene to repetitive sequences of rat liver DNA in vivo. Proceedings of the National Academy of Sciences of the United States of America 81 22 (1984) 6943-6947
16. Hatano R., Ebara M., Fukuda H., Yoshikawa M., Sugiura N., Kondo F., Yukawa M., and Saisho H. Fatty liver, chronic hepatitis C and hepatocellular carcinoma Accumulation of copper in the liver and hepatic injury in chronic hepatitis C. Journal of Gastroenterology and Hepatology 15 7 (2000) 786-791
17. Herzfeld A., and Greengar O. The effect of lymphoma and other neoplasms on hepatic and plasma enzymes of the host rat. Cancer Research 37 1 (1977) 231-238
18. Hiraku Y., Yamashita N., Nishiguchi M., and Kawanishi S. Catechol estrogens induce oxidative DNA damage and estradiol enhances cell proliferation. International Journal of Cancer 92 3 (2001) 333-337
19. Huang G.W., and Yang L.Y. Metallothionein expression in hepatocellular carcinoma. World Journal of Gastroenterology 8 4 (2002) 650-653
20. Ito Y., Matsuura N., Sakon M., Takeda T., Umeshita K., Nagano H., Nakamori S., Dono K., Tsujimoto M., Nakahara M., Nakao K., and Monden M. Both cell proliferation and apoptosis significantly predict shortened disease-free survival in hepatocellular carcinoma. British Journal of Cancer 81 4 (1999) 747-751
21. Jackson P.E., O'Connor P.J., Cooper D.P., Margison G.P., and Povey A.C. Associations between tissue-specific DNA alkylation, DNA repair and cell proliferation in the colon and colon tumour yield in mice treated with 1,2-dimethylhydrazine. Carcinogenesis 24 3 (2003) 527-533
22. Jacob C., Maret W., and Vallee B.L. Control of zinc transfer between thionein, metallothionein, and zinc proteins. Proceedings of the National Academy of Sciences of the United States of America 95 7 (1998) 3489-3494
23. Jia G., Tohyama C., and Sone H. DNA damage triggers imbalance of proliferation and apoptosis during development of preneoplastic foci in the liver of Long-Evans Cinnamon rats. International Journal of Oncology 21 4 (2002) 755-761
24. Jin R., Chow V.T.K., Tan P.H., Tan P.H., Dheen S.T., Duan W., and Bay B.H. Metallothionein 2A expression is associated with cell proliferation in breast cancer. Carcinogenesis 23 1 (2002) 81-86
25. Katakai K., Liu J., Nakajima K., Keefer L.K., and Waalkes M.P. Nitric oxide induces metallothionein (MT) gene expression apparently by displacing zinc bound to MT. Toxicology Letter 119 2 (2001) 103-108
26. Kawata T., Nakamura S., Nakayama A., Fukuda H., Ebara M., Nagamine T., Minami T., and Sakurai H. An improved diagnostic method for chronic hepatic disorder: analyses of metallothionein isoforms and trace metals in the liver of patients with hepatocellular carcinoma as determined by capillary zone electrophoresis and inductively coupled plasma-mass spectrometry. Biological and Pharmaceutical Bulletin 29 3 (2006) 403-409
27. Kiningham K., and Kasarskis E. Antioxidant function of metallothioneins. Journal of Trace Elements in Experimental Medicine 11 2-3 (1998) 219-226
28. Kolaja K.L., Stevenson D.E., Walborg Jr. E.F., and Klaunig J.E. Dose dependence of phenobarbital promotion of preneoplastic hepatic lesions in F344 rats and B6C3F1 mice: effects on DNA synthesis and apoptosis. Carcinogenesis 17 5 (1996) 947-954
29. Kubo S., Fukuda H., Ebara M., Ikota N., Saisho H., Nakagawa H., Ozawa T., Yukawa M., Kato K., Satoh T., Watayo T., and Sakurai H. Evaluation of distribution patterns for copper and zinc in metallothionein and superoxide dismutase in chronic liver diseases and hepatocellular carcinoma using high-performance liquid chromatography (HPLC). Biological and Pharmaceutical Bulletin 28 7 (2005) 1137-1141
30. 3H-thymidine for studies of hepatocellular proliferation in rodents. Carcinogenesis 10 7 (1989) 1341-1343
31. Liaw K.Y., Lee P.H., Wu F.C., Tsai J.S., and Lin-Shiau S.Y. Zinc, copper, and superoxide dismutase in hepatocellular carcinoma. American Journal of Gastroenterology 92 12 (1997) 2260-2263
32. Linder M.C., Wooten L., Cerveza P., Cotton S., Shulze R., and Lomeli N. Copper transport. American Journal of Clinical Nutrition 67 5 Suppl (1998) 965S-971S
33. Maeda T., Shimada M., Harimoto N., Tsujita E., Maehara S., Rikimaru T., Tanaka S., Shirabe K., and Maehara Y. Role of tissue trace elements in liver cancers and non-cancerous liver parenchyma. Hepatogastroenterology 52 61 (2005) 187-190
34. Maret W., and Vallee B.L. Thiolate ligands in metallothionein confer redox activity on zinc clusters. Proceedings of the National Academy of Sciences of the United States of America 95 7 (1998) 3478-3482
35. Mehta R. The potential for the use of cell proliferation and oncogene expression as intermediate markers during liver carcinogenesis. Cancer Letter 93 1 (1995) 85-102
36. Murata M., Midorikawa K., Koh M., Umezawa K., and Kawanishi S. Genistein and daidzein induce cell proliferation and their metabolites cause oxidative DNA damage in relation to isoflavone-induced cancer of estrogen-sensitive organs. Biochemistry 43 9 (2004) 2569-2577
37. Nakamura S., Kawata T., Nakayama A., Kubo K., Minami T., and Sakurai H. Implication of the differential roles of metallothionein 1 and 2 isoforms in the liver of rats as determined by polyacrylamide-coated capillary zone electrophoresis. Biochemical and Biophysical Research Communications 320 4 (2004) 1193-1198
38. Nakayama A., Fukuda H., Ebara M., Hamasaki H., Nakajima K., and Sakurai H. A new diagnostic method for chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma based on serum metallothionein, copper, and zinc levels. Biological and Pharmaceutical Bulletin 25 4 (2002) 426-431
39. Nakayama A., Nishiguchi M., and Sakurai H. Biological regulation and disordered diseases. differential reactivity of metallothionein isoforms I and II on active oxygen species. Biomedical Research on Trace Elements 13 1 (2002) 78-84
40. Palmiter R.D. The elusive function of metallothioneins. Proceedings of the National Academy of Sciences of the United States of America 95 15 (1998) 8428-8430
41. Pitot H.C. Altered hepatic foci: their role in murine carcinogenesis. Annual Review of Pharmacology and Toxicology 30 (1990) 465-500
42. Poirier L.A. An introduction to selected concepts in metal carcinogenesis. In: Chang L.W. (Ed). Toxicology of Metals (1996), Lewis Publisher, New York 287-298
43. Preat V., de Gerlache J., Lans M., Taper H., and Roberfroid M. Influence of the nature and the dose of the initiator on the development of premalignant and malignant lesions in rat hepatocarcinogenesis. Teratogenesis Carcinogenesis and Mutagenesis 6 3 (1986) 165-172
44. Qin L.X., and Tang Z.Y. The prognostic molecular markers in hepatocellular carcinoma. World Journal of Gastroenterology 8 3 (2002) 385-392
45. Sarkar A., Basak R., Basak J., and Chatterjee M. Betacarotene prevents rat liver chromosomal aberrations and DNA chain break after a single injection of diethylnitrosamine. British Journal of Cancer 76 7 (1997) 855-861
46. Sato M., and Kondoh M. Recent studies on metallothionein: protection against toxicity of heavy metals and oxygen free radicals. Tohoku Journal of Experimental Medicine 196 1 (2002) 9-22
47. Sato S., Shimizu M., Hosokawa T., Saito T., Okabe M., Niioka T., and Kurasaki M. Distribution of zinc-binding metallothionein in cirrhotic liver of rats administered zinc. Pharmacology & Toxicology 87 6 (2000) 292-296
48. Sawaki M., Enomoto K., Hattori A., Tsuzuki N., Sawada N., and Mori M. Elevation of metallothionein level in preneoplastic lesions during chemical hepatocarcinogenesis of the Fischer 344 rat. Toxicology Letters 108 1 (1999) 55-61
49. Schmidt C.J., and Hamer D.H. Cell specificity and an effect of ras on human metallothionein gene expression. Proceedings of the National Academy of Sciences of the United States of America 83 10 (1986) 3346-3350
50. Schulte-Hermann R., Bursch W., Kraupp-Grasl B., Oberhammer F., Wagner A., and Jirtle R. Cell proliferation and apoptosis in normal liver and preneoplastic foci. Environmental Health Perspectives 101 Suppl 5 (1993) 87-90
51. Schulte-Hermann R., Ohde G., Schuppler J., and Timmermann-Trosiener I. Enhanced proliferation of putative preneoplastic cells in rat liver following treatment with the tumor promoters phenobarbital, hexachlorocyclohexane, steroid compounds, and nafenopin. Cancer Research 41 6 (1981) 2556-2562
52. Schulte-Hermann R., Timmermann-Trosiener I., and Schuppler J. Response of liver foci in rats to hepatic tumor promoters. Toxicologic Pathology 10 (1982) 63-70
53. Shen J., Wanibuchi H., Salim E.I., Wei M., Kinoshita A., Yoshida K., Endo G., and Fukushima S. Liver tumorigenicity of trimethylarsine oxide in male Fischer 344 rats-association with oxidative DNA damage and enhanced cell proliferation. Carcinogenesis 24 11 (2003) 1827-1835
54. Shivapurkar N., Hoover K.L., and Poirier L.A. Effect of methionine and choline on liver tumor promotion by phenobarbital and DDT in diethylnitrosamine-initiated rats. Carcinogenesis 7 4 (1986) 547-550
55. St Croix C.M., Wasserloos K.J., Dineley K.E., Reynolds I.J., Levitan E.S., and Pitt B.R. Nitric oxide-induced changes in intracellular zinc homeostasis are mediated by metallothionein/thionein. American Journal of Physiology- Lung Cellular and Molecular Physiology 282 2 (2002) L185-L192
56. Starborg M., Gell K., Brundell E., and Hoog C. The murine Ki-67 cell proliferation antigen accumulates in the nucleolar and heterochromatic regions of interphase cells and at the periphery of the mitotic chromosomes in a process essential for cell cycle progression. Journal of Cell Sciences 109 Pt 1 (1996) 43-53
57. Stewart H.L., Williams G.M., Keysser C.H., Lombard L.S., and Montail R.J. Histological typing of liver tumors of the rat. Journal of the National Cancer Institute 64 (1980) 117-207
58. Suzuki K.T., Rui M., Ueda J.I., and Ozawa T. Production of hydroxyl radicals by copper-containing metallothionein; roles as prooxidant. Toxicology and Applied Pharmacology 141 1 (1996) 231-237
59. Tashiro H., Kawamoto T., Okubo T., and Koide O. Variation in the distribution of trace elements in hepatoma. Biological Trace Element Research 95 1 (2003) 49-63
60. Tashiro-Itoh T., Ichida T., Matsuda Y., Satoh T., Sugiyama M., Tanaka Y., Ishikawa T., Itoh S., Nomoto M., and Asakura H. Metallothionein expression and concentrations of copper and zinc are associated with tumor differentiation in hepatocellular carcinoma. Liver 17 6 (1997) 300-306
61. Tatematsu M., Nagamine Y., and Farber E. Stable phenotypic expression of glutathione-S-transferase placental type and unstable phenotypic expression of γ-glutamyl transpeptidase in rat liver preneoplastic and neoplastic lesions. Carcinogenesis 9 2 (1988) 215-220
62. Umemura T., Kai S., Hasegawa R., Kanki K., Kitamura Y., Nishikawa A., and Hirose M. Prevention of dual promoting effects of pentachlorophenol, an environmental pollutant, on diethylnitrosamine-induced hepato-and cholangiocarcinogenesis in mice by green tea infusion. Carcinogenesis 24 6 (2003) 1105-1109
63. Umemura T., Sai-Kato K., Takagi A., Hasegawa R., and Kurokawa Y. Oxidative DNA damage and cell proliferation in the livers of B6C3F1 mice exposed to pentachlorophenol in their diet. Fundamental and Applied Toxicology 30 2 (1996) 285-289
64. Wang S.S., Zhang T., Wang X.L., Hong L., and Qi Q.H. Effect of arsenic trioxide on rat hepatocarcinoma and its renal cytotoxicity. World Journal of Gastroenterology 9 5 (2003) 930-935
65. Williams G.M., Gebhardt R., Sirma H., and Stenback F. Non-linearity of neoplastic conversion induced in rat liver by low exposures to diethylnitrosamine. Carcinogenesis 14 10 (1993) 2149-2156